NASDAQ: IMUXImmunic Inc Stock Ownership - Who owns Immunic?
Insider buying vs selling
Have Immunic Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Glenn Whaley | Chief Financial Officer | 2023-05-15 | 5,000 | $1.75 | $8.75kBuy |
| Joerg Neermann | Director | 2022-12-14 | 47,000 | $1.26 | $59.03kBuy |
| Joerg Neermann | Director | 2022-12-13 | 35,000 | $1.25 | $43.61kBuy |
| Joerg Neermann | Director | 2022-11-23 | 18,000 | $1.39 | $25.02kBuy |
| Daniel Vitt | President and CEO | 2022-11-22 | 8,000 | $1.35 | $10.80kBuy |
| Glenn Whaley | Chief Financial Officer | 2022-11-07 | 5,000 | $1.50 | $7.48kBuy |
IMUX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IMUX insiders and whales buy or sell their stock.
IMUX Shareholders
What type of owners hold Immunic Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Muneer A. Satter | 15.99% | 7,132,277 | $10.20M | Insider |
| Rtw Investments LP | 9.63% | 4,294,459 | $6.14M | Institution |
| V. Cooperatieve Ua Lsp | 4.85% | 2,162,782 | $3.09M | Insider |
| Omega Fund Management LLC | 4.01% | 1,788,160 | $2.56M | Institution |
| Gratus Capital LLC | 3.76% | 1,678,793 | $2.40M | Institution |
| Vanguard Group Inc | 3.76% | 1,676,274 | $2.40M | Institution |
| Vincent Ossipow | 3.08% | 1,371,494 | $1.96M | Insider |
| Fund Nv | 3.08% | 1,371,494 | $1.96M | Insider |
| Life Bioventure V. Sarl Global | 3.08% | 1,371,494 | $1.96M | Insider |
| Bvf Inc | 2.58% | 1,149,425 | $1.64M | Institution |
IMUX vs Biotech Stocks
Immunic Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.